Skip to content

Pilot Efficacy Study of the Stendo Pulsating Suit in Patient With Leg Lymphoedema

Pilot Efficacy Study of the Stendo Pulsating Suit in Patient With Leg Lymphoedema

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02234674
Enrollment
25
Registered
2014-09-09
Start date
2014-09-30
Completion date
2015-02-28
Last updated
2015-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Lower Limb Lymphedema, Secondary Lower Limb Lymphedema

Keywords

Pulsating suit, lymphedema, leg volume

Brief summary

This study aims at evaluating the efficacy of the Stendo pulsating suit in patients with a leg lymphedema hospitalized for intensive Complex Decongestive Physiotherapy (CDP). This study is a pilot controlled randomized study with two arms.

Interventions

OTHERCurrent intensive CDP

Standard Intensive CDP including * manual lymph drainage, * pressotherapy and * bandaging

OTHERintensive CDP where Stendo pulsating suit replaces pressotherapy

The intervention consist to perform daily during 5 days an intensive CDP where pressotheray is replaced by Stndo pulsating suit sessions.

Sponsors

Stendo
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient with a primary or secondary lympedema clinically diagnosed (Stemmer Sign) of one or two legs. * Patient with a lympedema stage II (persistent) or III according to the classification of the International Society of Lymphoedema (ISL) * Patient aged 18 or more

Exclusion criteria

* Patient with a severe heart, kidney or liver failure, * Patient with an advanced obstructive arterial disease * Patient with a recent and progressive deep venous thrombosis

Design outcomes

Primary

MeasureTime frameDescription
volume of the most affected legbaseline ; after 5 days intensive CDPChange in % of the volume of the most affected leg according to disk model method

Secondary

MeasureTime frameDescription
Quality of Lifebaseline ; after 5 days intensive CDP36 health survey questionnaire (SF-36) and Visual Analogical Scale

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026